Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2012

View Archived Issues

Novel FLAP inhibitors divulged by Boehringer Ingelheim

FKD Therapies clear to launch phase II Instiladrin study

Scientists in China links gene's expression levels to severity of cognitive impairment

Novel BACE inhibitor shows promise to treat Alzheimer's disease

Novel agents for hepatitis C prepared at Cocrystal Discovery

Spanish researchers patent new CB1 receptor ligands

Novel TLR7 agonists disclosed

Preclinical evaluation of OMS-824 complete

New antisense oligonucleotides designed at miRagen Therapeutics

Novel antivirals disclosed by Abbott

GSK vaccine candidate for shingles enters phase III study

MetaMax focuses on development of MM-D37K

Novel bile acid receptor agonists presented by IRM

Antinicotine gene therapy as a novel approach to nicotine addiction

Johnson & Johnson reviews highlights of second quarter 2012

NVP-BKM120 shows potential in models of follicular lymphoma

Milestone met in Amgen/Array BioPharma collaboration

Soricimed Biopharma to design biologic drug conjugates for oncology indications

FDA clears pivotal trials of sustained-release microinsert in uveitis

Phrixus Pharmaceuticals reports preclinical results for Carmeseal

Phase I trial commences of combination therapy for ovarian cancer

Phase I/II Actimab-A trial advances

Cytomedix collaborates with Duke University on brain cancer study

University of Alberta kicks off phase I/II study of pan-caspase inhibitor

NIH to test maraviroc-based drug regimens for HIV prevention

Sanofi and Regeneron launch phase III program for LDL-lowering antibody

Investigators at Bristol-Myers Squibb identify novel dAbs targeting CD40-L

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...